Giuseppe Lo Russo

Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade

Giuseppe Lo Russo, Massimo Moro, Michele Sommariva et al. · Clinical Cancer Research · 2018 · 407 citations · Full text

Medicine, Immunology, Oncology +17

Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors

Giovanni Fucà, Giulia Galli, M. Poggi et al. · ESMO Open · 2019 · 212 citations · Full text

Life Sciences, Immunology, Oncology +15

Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors

Andrew J. Wagner, Udai Banerji, Amit Mahipal et al. · Journal of Clinical Oncology · 2017 · 125 citations

Medicine, Oncology, Pharmacology +17

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial

Quincy S. Chu, Laurent Greillier, Wei Tu et al. · The Lancet · 2023 · 101 citations

Medicine, Oncology, Pharmacology +15

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Sara Pusceddu, Claudio Vernieri, Massimo Di Maïo et al. · Gastroenterology · 2018 · 89 citations · Full text

Medicine, Endocrinology, Oncology +11